The Justice Department brought false claim charges involving Medicare against Chemed Corp. and its hospice subsidiary over allegations it billed the program for crisis services that were not necessary or not provided, or that did not meet program requirements. Chemed said it will strongly contest the lawsuit and that it and its hospices work hard to comply with industry standards and regulations and to "ensure our services are provided only to eligible patients."

Related Summaries